AzTrials
AzTrials

Chronic Low-back PainNCT05919446

The Feasibility, Potential Efficacy, and Experiences of Using a Group-based Acceptance and Commitment Therapy Among Older People With Chronic Low Back Pain

A study testing Acceptance and commitment therapy (ACT) and back exercise in people with Chronic Low-back Pain, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

No study has investigated the effects of ACT on community-dwelling Chinese older adults. Given that clinical practice guidelines have recommended exercise therapy for treating people with CLBP, a combination of ACT and exercise therapy may yield better clinical outcomes than exercise alone among community-dwelling… Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Chronic Low-back Pain
What is being tested?
Acceptance and commitment therapy (ACT) and back exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteHong Kong
Study dates
1 Aug 2023to 30 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • have non-specific LBP in or near the lumbosacral spine with or without leg pain that lasts for at least 3-months in the last 12 months
  • have sought some medical or healthcare professional treatments for CLBP
  • able to read and write at an adequate level of proficiency in Chinese
  • Mini-Mental Status Examination (MMSE) scores 23 or above

Who cannot join

  • people with malignant pain or lumbar spinal stenosis
  • confirmed dementia
  • severe cognitive impairment
  • serious psychiatric or psychological disorders
  • Mini-Mental Status Examination (MMSE) scores below 23

Trial locations and contacts

1 site in 1 country.

Arnold Wong, PhD contact

27666741

arnold.wong@polyu.edu.hk

Hong Kong1 site, 1 recruiting
  • The Hong Kong Polytechnic University

    Hong Kong

    Arnold Wong, PhD, 2766 6741, arnold.wong@polyu.edu.hk

    Arnold Wong, PhD

    Recruiting

Other trials in Hong Kong

About this study

Official title: The Feasibility, Potential Efficacy, and Experiences of Using a Group-based Acceptance and Commitment Therapy Among Older People With Chronic Low Back Pain: a Pilot Randomized Controlled Trial

No study has investigated the effects of ACT on community-dwelling Chinese older adults. Given that clinical practice guidelines have recommended exercise therapy for treating people with CLBP, a combination of ACT and exercise therapy may yield better clinical outcomes than exercise alone among community-dwelling older adults with CLBP. A double-blinded (participants and statistician) pilot randomized controlled trial (RCT) will be conducted to evaluate the feasibility and the relative effects of ACT plus back exercise training as compared to exercise alone in improving psychological flexibility, physical wellbeing, and quality of life of community-dwelling older people with CLBP. Further, a qualitative research study will be conducted to understand the experiences of participating in ACT and back exercise training in older people with CLBP (including identifying facilitators and barriers to participation).

Read the detailed description

Participants will be recruited from rehabilitation clinics, or community centres by posters posted in these locations. A total of 30 older people with LBP will be recruited and randomized into either a 4-week ACT plus back exercise group, or a back exercise control group. Immediately after the 4-week treatment, participants will be invited to complete another set of questionnaires that are identical to their baseline questionnaires to evaluate the effects of interventions on their pain, physical function, psychological wellbeing, and quality of life. At 3-month post-treatment, participants will be invited to complete the identical questionnaires again.

Being tested
Acceptance and commitment therapy (ACT), back exercise
Keywords
Chronic Low-back Pain (CLBP), Acceptance and commitment therapy (ACT), psychological flexibility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acceptance and commitment therapy (ACT)Behavioural

    Each session in the ACT group will include the first hour of ACT intervention followed by 1 hour of back exercise class. The ACT group will be led by a trained ACT counsellor and a trained exercise trainer.

  • back exerciseBehavioural

    The control group will undergo 1 hour of back exercise class, while the control group will be led by a trained exercise trainer.

Study groups in NCT05919446
Study groupRoleWhat they receive
Older people with ACT interventionExperimental4 week ACT plus back exercise group
Receives: Behavioral: Acceptance and commitment therapy (ACT); Behavioral: back exercise
Older people without ACT interventionOther4-week back exercise control group
Receives: Behavioral: back exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline of psychological flexibility at immediately after the 4-week treatments

    The 7-item Chinese version of the Acceptance and Action Questionnaire II (AAQ-II) will be used to measure participants' psychological flexibility. It comprises 7 statements, which are rated on a 7-point scale, where 1 means "never true" and 7 means "always true." The maximum total score is 49. Higher total scores mean less flexibility. AAQ-II has been cross-culturally adapted and validated among local adolescents and has demonstrated satisfactory internal consistency and test-retest reliability.

    Measured: Baseline and at immediately after the 4-week treatments

Secondary outcomes (6)
  1. Change of LBP intensity

    An 11-point numeric pain rating scale will be used to measure LBP intensity, where 0 means no pain and 10 means the worst imaginable pain. Participants need to report their back pain in the current moment, in the last 24 hours and the last 3 months.

    Measured: Baseline, immediately after the 4-week treatments, and at 3-month post-treatment

  2. Change of LBP-related disability

    The Chinese version of 24-item Roland Morris Disability Index will be used to evaluate the LBP-related disability in older adults.30 It consists of 24 yes/no items related to LBP-related functional limitations. The summation of the scores of items with "yes" answer indicates the severity of LBP-related disability. The maximum score is 24.

    Measured: Baseline, immediately after the 4-week treatments, and at 3-month post-treatment

  3. Change of health-related quality of life

    The Chinese version of EQ-5D-5L will be used to measure health-related quality of life (HRQOL) in our participants. It comprises 5 items related to mobility, self-care, daily activities, pain/discomfort, and anxiety/depression. Each item has 5 options (no problem, slight problems, moderate problems, severe problems, extreme problems/unable to). It has been found to useful in monitoring HRQOL responses to treatment.

    Measured: Baseline, immediately after the 4-week treatments, and at 3-month post-treatment

  4. Change of depression, anxiety, and stress

    The Chinese version of 21-item Depression, Anxiety Stress Scales (DASS) will be used to evaluate depression (7 items), anxiety (7 items), and stress (7 items) in older adults. Each item is rated on a 4-point scale ranging from 0 (not at all) to 3 (most of the time). Higher scores imply more mental health issues. It has been cross-culturally adapted to Hong Kong settings.

    DASS has demonstrated excellent internal consistency for depression, anxiety, and stress subscales.

    Measured: Baseline, immediately after the 4-week treatments, and at 3-month post-treatment

  5. Overall perceived changes in symptom severity, treatment response and the efficacy of treatment

    Global impression of change scale will be used to evaluate the overall perceived changes in symptom severity, treatment response and the efficacy of treatment immediately after the 4 week interventions.

    Measured: Baseline, immediately after the 4-week treatments, and at 3-month post-treatment

  6. Change from baseline of psychological flexibility at 3-month post-treatment

    The 7-item Chinese version of the Acceptance and Action Questionnaire II (AAQ-II) will be used to measure participants' psychological flexibility. It comprises 7 statements, which are rated on a 7-point scale, where 1 means "never true" and 7 means "always true." The maximum total score is 49. Higher total scores mean less flexibility. AAQ-II has been cross-culturally adapted and validated among local adolescents and has demonstrated satisfactory internal consistency and test-retest reliability.

    Measured: Baseline and at 3-month post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2023
  2. Study start1 Aug 2023
  3. Primary completion30 Jul 2025 (estimated)
  4. Study completion30 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05919446
Sponsor's protocol ID
HSEARS20230104002
Status last verified
Feb 2024
First submitted
30 May 2023
Last updated
28 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Liu JQJ, Mak YW, Tang ALY, Kwan C, Al Zoubi F, Wong TKT, Tsang GSH, Kwong HCW, Lai SWT, Sze SPS, Hui KTK, Cheung CKC, Samartzis D, Chow KKS, Wong AYL. Effects of acceptance and commitment therapy plus exercise for older adults with chronic low back pain: A preliminary cluster randomized controlled trial with qualitative interviews. J Pain. 2025 May;30:105350. doi: 10.1016/j.jpain.2025.105350. Epub 2025 Feb 26.

    PubMed 40020954

Questions about this trial

What is this clinical trial studying?

A study testing Acceptance and commitment therapy (ACT) and back exercise in people with Chronic Low-back Pain, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Arnold Wong, PhD (27666741, arnold.wong@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline of psychological flexibility at immediately after the 4-week treatments (time frame: Baseline and at immediately after the 4-week treatments). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05919446, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in